Paper36748937
Screening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system.
Masson W and 8 others. Arch Endocrinol Metab, 2023. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Screening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system. Papers, record 36748937. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36748937
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Screening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperlipoproteinemia Type I | Major topic |
| Male | |
| Humans | |
| Middle Aged | |
| Female | |
| Cross-Sectional Studies | |
| Universities | |
| Triglycerides |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30165992 | Familial Chylomicronemia Syndrome: Clinical Characteristics and Long-Term Cardiovascular Outcomes. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/30165992 | PubMed |
| 2 | 35177334 | Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2022 | https://conductscience.org/library/papers/35177334 | PubMed |
| 3 | 30655019 | Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia. | Atherosclerosis | 2019 | https://conductscience.org/library/papers/30655019 | PubMed |
| 4 | 35207255 | Volanesorsen: A New Era in the Treatment of Severe Hypertriglyceridemia. | J Clin Med | 2022 | https://conductscience.org/library/papers/35207255 | PubMed |
| 5 | 29980054 | Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score". | Atherosclerosis | 2018 | https://conductscience.org/library/papers/29980054 | PubMed |
| 6 | 31840878 | Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia. | J Intern Med | 2020 | https://conductscience.org/library/papers/31840878 | PubMed |
| 7 | 11588264 | An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. | Science | 2001 | https://conductscience.org/library/papers/11588264 | PubMed |
| 8 | 35144640 | Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia. | Lipids Health Dis | 2022 | https://conductscience.org/library/papers/35144640 | PubMed |
| 9 | 23769508 | [Basic mechanisms: structure, function and metabolism of plasma lipoproteins]. | Clin Investig Arterioscler | 2013 | https://conductscience.org/library/papers/23769508 | PubMed |
| 10 | 30466821 | Severe hypertriglyceridemia is primarily polygenic. | J Clin Lipidol | 2019 | https://conductscience.org/library/papers/30466821 | PubMed |
| 11 | 16176166 | Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. | Clin Chem Lab Med | 2005 | https://conductscience.org/library/papers/16176166 | PubMed |
| 12 | 32649781 | Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic. | Eur J Clin Invest | 2020 | https://conductscience.org/library/papers/32649781 | PubMed |
| 13 | 29804909 | Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span. | J Clin Lipidol | 2018 | https://conductscience.org/library/papers/29804909 | PubMed |
| 14 | 27998715 | Diagnostic algorithm for familial chylomicronemia syndrome. | Atheroscler Suppl | 2017 | https://conductscience.org/library/papers/27998715 | PubMed |
| 15 | 22962670 | Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. | J Clin Endocrinol Metab | 2012 | https://conductscience.org/library/papers/22962670 | PubMed |
| 16 | 17032446 | Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans. | BMC Med Genet | 2006 | https://conductscience.org/library/papers/17032446 | PubMed |
| 17 | 30237456 | The effect of serum triglyceride concentration on the outcome of acute pancreatitis: systematic review and meta-analysis. | Sci Rep | 2018 | https://conductscience.org/library/papers/30237456 | PubMed |
| 18 | 32852651 | Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment. | Curr Atheroscler Rep | 2020 | https://conductscience.org/library/papers/32852651 | PubMed |
| 19 | 34468855 | Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS). | Curr Atheroscler Rep | 2021 | https://conductscience.org/library/papers/34468855 | PubMed |
| 20 | 34920815 | Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion. | J Clin Lipidol | 2021 | https://conductscience.org/library/papers/34920815 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41026863 | A multi-society Delphi consensus statement on the diagnosis of familial chylomicronemia syndrome. | Arch Endocrinol Metab | 2025 | https://conductscience.org/library/papers/41026863 | PubMed |
| 40360374 | Recognition and management of persistent chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology. | J Clin Lipidol | 2025 | https://conductscience.org/library/papers/40360374 | PubMed |
| 40242365 | Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology. | Am J Prev Cardiol | 2025 | https://conductscience.org/library/papers/40242365 | PubMed |
| 39696078 | An unusual case of type I hyperlipidemia - infant with acute encephalopathy, bulging fontanel, vomiting and pink blood: a case report. | BMC Pediatr | 2024 | https://conductscience.org/library/papers/39696078 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOA5 | 116519 | PubTator's text mining | https://conductscience.org/library/genes/116519 | NCBI Gene |
| APOB | 338 | PubTator's text mining | https://conductscience.org/library/genes/338 | NCBI Gene |
| APOC2 | 344 | PubTator's text mining | https://conductscience.org/library/genes/344 | NCBI Gene |
| APOC3 | 345 | PubTator's text mining | https://conductscience.org/library/genes/345 | NCBI Gene |
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| GPIHBP1 | 338328 | PubTator's text mining | https://conductscience.org/library/genes/338328 | NCBI Gene |
| LMF1 | 64788 | PubTator's text mining | https://conductscience.org/library/genes/64788 | NCBI Gene |
| LPL | 4023 | PubTator's text mining | https://conductscience.org/library/genes/4023 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36748937
GET https://conductscience.org/api/papers/v1/36748937/references?page=2